Atlas Trials

Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Clinical trial NCT03932071 · UNKNOWN

Trial details

NCT number
NCT03932071
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Lung MetastasesTumor Necrosis
Start date
2017-01-01
Primary completion
2020-01-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.